Results 181 to 190 of about 21,990 (200)
Some of the next articles are maybe not open access.

Oncolytic Virotherapy and the Tumor Microenvironment

2017
Oncolytic viral therapy is a promising approach to treat many malignancies, including breast, colorectal, hepatocellular, and melanoma. The best results are seen when using "targeted and armed" viruses. These are viruses that have been genetically modified to selectively replicate within cancer cells and express specific transgenes that alter the tumor
Sara E, Berkey   +2 more
openaire   +2 more sources

Immunomodulation in Oncolytic Measles Virotherapy

2019
With the recognition of oncolytic virotherapy as an immunotherapy, the distinct interactions between oncolytic agents and the immune system have come into focus. The role of the immune system in oncolytic virotherapy is somewhat ambiguous: While preexisting or arising immunity directed against viral antigens may preclude efficient viral replication and
Laura, Dietz, Christine E, Engeland
openaire   +2 more sources

Oncolytic Virotherapy-Mediated Anti-Tumor Response: A Single-Cell Perspective

Cancer Cell, 2021
Christian Beisel   +2 more
exaly  

A Critical Virus Production Rate for Efficiency of Oncolytic Virotherapy

European Journal of Applied Mathematics, 2021
Youshan Tao
exaly  

Oncolytic Virotherapy for Malignant Gliomas

Journal of Clinical Oncology, 2018
Peter A, Forsyth, Daniel, Abate-Daga
openaire   +2 more sources

Oncolytic Virotherapy: A Contest Between Apples and Oranges

Molecular Therapy, 2017
Stephen J Russell, Kah-Whye Peng
exaly  

Home - About - Disclaimer - Privacy